gemcitabine has been researched along with cx 5461 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
El Hassouni, B; Giovannetti, E; Immordino, B; Mantini, G; Peters, GJ | 1 |
1 other study(ies) available for gemcitabine and cx 5461
Article | Year |
---|---|
CX-5461 Inhibits Pancreatic Ductal Adenocarcinoma Cell Growth, Migration and Induces DNA Damage.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Benzothiazoles; Biomarkers, Tumor; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Movement; Cell Proliferation; Deoxycytidine; DNA Damage; Epithelial-Mesenchymal Transition; Gemcitabine; Gene Expression Regulation, Neoplastic; Humans; Models, Biological; Naphthyridines; Pancreatic Neoplasms; RNA, Messenger; Spheroids, Cellular | 2019 |